Holland Die Condition Monitor - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Holland Die Condition Monitor


I Holland, the leading specialist manufacturer of tablet tooling for the pharmaceutical and nutraceutical industries, has recently launched the Holland Die Condition Monitor (HDCM).

HDCM is designed to monitor the condition of die bores, for any die type including multi-tips. When used at regular intervals it ensures that optimum life is achieved from dies and helps to prevent the production of damaged tablets.

A high accuracy probe is used, to measure the die bore wear (usually displayed  in the form of rings) and when used regularly it can help in the prediction  and planning of required expenditure on new die sets

HDCM can be fully integrated with I Holland’s Approve® system for a complete measurement solution, which incorporates tip diameter, barrel diameter, punch concentricity and die bore diameter.

When used as part of I Holland’s recommended PharmaCare® 7-Step Process, a professional punch and die maintenance and storage programme, HDCM assists punch and die users to ensure that critical tooling dimensions have stayed within tolerance following tool polishing or repair work, and helps to ensure proactive monitoring of tooling inventory.

 

I Holland

Website: www.iholland.co.uk

E-mail: clare.taylor@iholland.co.uk

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here